employer cover photo
employer logo
employer logo

CRISPR Therapeutics

Engaged Employer

Good stepping stone, ready to leave - Research Associate II, Analytical Development CRISPR Therapeutics Employee Review

2.0
Jan 26, 2022
Recommend
CEO approval
Business Outlook

Pros

Poor compensation for cutting edge work means you can get quickly snapped up by a better company with better compensation packages

Cons

- lots of talk of "overachievement" when it comes to corporate goals, but doesn't seem to translate to salary increases - annual "raises" are below the annual inflation rate - CEO is openly disparaging of employees - toxic employees leftover from an earlier acquisition make for an unwelcoming work environment

Explore other reviews about CRISPR Therapeutics

5.0
Feb 2, 2026
Recommend
CEO approval
Business Outlook

Pros

Exciting environment and collaborative teams

Cons

Usual pain points of a growing organization

1.0
Jun 7, 2026
Recommend
CEO approval
Business Outlook

Pros

Benefits are good and lunch is subsidized. There are interesting projects and smart people working on them, the work itself isn’t the problem.

Cons

Executive pay is disconnected from company performance. Chronic understaffing has created unsustainable workloads with no relief in sight, and work-life balance is essentially nonexistent. Execs have created a surveillance and monitoring culture that has undermined trust and psychological safety across the organization. For a company that claims to be an innovation and science leader, there is no dedicated head of research which raises real questions about where this company is actually headed. Strategy shifts constantly with little to no communication to the people keeping it afloat.

See reviews by: Helpful|Rating|Date|All